Page 1

Laura T. Pizzi, PharmD, MPH, RPh Curriculum Vitae

Email: laura.pizzi@rutgers.edu Office phone: (848) 445-6825

Expertise: Applied health economic and outcomes analyses of drugs and other healthcare interventions. Strong methodological expertise in designing and conducting economic analyses (cost effectiveness, cost benefit) alongside clinical trials and constructing health economic models (budget impact, decision analytic, Markov simulation). Seasoned educator on these topics. Research profile available at: https://www.researchgate.net/profile/Laura_Pizzi

Education:

2003 Masters in Public Health (epidemiology/quantitative methods cross track), Rutgers School of Public Health, Piscataway NJ

1997 Fellow, Pharmacoeconomics and Outcomes Research, University of Pennsylvania Medical Center, Philadelphia PA

1996 Doctor of Pharmacy (PharmD) – conferred with BS in Pharmacy (with honors) via doctoral track in program, Rutgers Ernest Mario School of Pharmacy, Piscataway NJ

Positions: January 2017-present Director, Health Outcomes, Policy and Economics (HOPE)

Program, Rutgers University

June 2015- present Chair, Faculty Advisor Council, International Society for Pharmacoeconomics and Outcomes Research

December 2015-May 2017 Co-Chair of Research, International Society of

Pharmacoeconomics and Outcomes Research Annual Meetings

July 2013-January 2017 Professor, Department of Pharmacy Practice, Jefferson College of Pharmacy

July 2010-July 2013 Associate Professor, Department of Pharmacy Practice, Jefferson College of Pharmacy

August 2007-July 2010 Director, Doris N. Grandon Center for Health Economics and Outcomes Research, Jefferson School of Population Health, Philadelphia PA

Laura T. Pizzi Page 2

July 2003-August 2007 Associate Director of Research, Department of Health Policy, Jefferson Medical College, Philadelphia PA

July 2001-July 2003 Project Director, Office of Health Policy and Clinical Outcomes, Thomas Jefferson University, Philadelphia PA

February 2001-July 2001 Consultant in Pharmacoeconomics Research, Office of Health Policy and Clinical Outcomes, Thomas Jefferson University, Philadelphia PA

September 2000-February 2001 Consultant in Pharmacoeconomics Research, SimStar

Internet Solutions, Princeton NJ and Epotec Inc., Wilmington, Delaware

August 1999-August 2000 Project Manager in Outcomes Research, HealthAnswers.com, a division of HealthAnswers, Inc., Pennington NJ

August 1998- July 1999 Manager, Outcomes Research, Hastings Healthcare Group, Pennington NJ

July 1997- August 1998 Clinical Information Specialist, Hastings Healthcare Group Pennington NJ

February 1996- July 1996 Pharmacist, CVS Pharmacy, Bergen County New Jersey

Faculty Appointments:

February 2017-present Professor, Department of Health Systems and Policy, Rutgers School of Public Health, Piscataway NJ

January 2017-present Professor, Department of Pharmacy Practice, Ernest Mario School of Pharmacy, Rutgers University, Piscataway NJ

July 2013-January 2017 Professor, Department of Pharmacy Practice, Jefferson College of Pharmacy, Philadelphia PA

November 2004-January 2017 Full Member, Graduate Faculty, Jefferson College of Graduate Studies, Philadelphia PA

July 2010-July 2013 Associate Professor, Department of Pharmacy Practice, Jefferson College of Pharmacy

January 2009-June 2010 Associate Professor, Jefferson School of Population

Health

November 2005-January 2009 Research Associate Professor of Health Policy, Jefferson Medical College, Philadelphia PA

August 2006-August 2007 Adjunct Assistant Professor of Pharmaceutical Business, University of the Sciences in Philadelphia, Philadelphia PA

September 1999-September 2001 Adjunct Instructor, Rutgers University College of Pharmacy, Piscataway NJ

March 1998-March 1999 Adjunct Clinical Assistant Professor, University of Rhode Island College of Pharmacy, Kingston RI

Laura T. Pizzi Page 3

Teaching Experience:

Program Director

2017-present Program Director, Masters of Science in Health Outcomes, Policy, and Economics, Rutgers University

2008- 2010 Program Director, Masters of Science in Applied Health Economics. Jefferson School of Population Health

Course Instructor

2017-present Course Instructor, Independent Research Elective in Health Economics, Rutgers School of Public Health, Piscataway NJ

2012-2016 Course Instructor, PHRM 599 Independent Research Elective in Pharmacoeconomics, Jefferson College of Pharmacy, Philadelphia PA.

2011-2016 Course Instructor, PHRM 551 Pharmacoeconomics and Health Outcomes, Jefferson College of Pharmacy, Philadelphia PA

2008-2016 Course Instructor, PHRM 519 Healthcare Delivery Systems, Jefferson College of Pharmacy, Philadelphia PA

2010 Course Instructor, PB 772 Principles of Pharmaceutical Economics, Ernest Mario School of Pharmacy, Rutgers University, Piscataway NJ

2006-2009 Course Instructor, Health Policy 401 (clerkship experience for 4th year medical students), Jefferson Medical College, Philadelphia PA

2003-2009 Course Instructor, GC650: Economic Analysis of Health Care Interventions, Jefferson College of Graduate Studies, Philadelphia PA

2006-2007 Course Instructor, Introduction to Health Policy, Department of Pharmaceutical and Healthcare Business, University of the Sciences in Philadelphia, Pharmaceutical MBA Program (online course)

2005-2006 Course Instructor, Clinical Research: From Policy to Practice, Thomas Edison State College, Trenton NJ (online course)

2004 Co-Instructor, PB772: Introduction to Health Policy, University of the Sciences of Philadelphia, Pharmaceutical MBA Program

Lecturer

2011-present PB 772 Principles of Pharmaceutical Economics, Ernest Mario School of Pharmacy, Rutgers University, Piscataway NJ

2013-2016 PHRM 572 Academic Pharmacy, Jefferson College of Pharmacy, Philadelphia PA

Laura T. Pizzi Page 4

2012-2016 PHRM 511 Biostatistics, Jefferson College of Pharmacy, Philadelphia PA

2015 MEDS I6200 Cost Analysis and the Business of Translation in Healthcare. Grove School of Engineering, City College of New York, New York, NY

2011-2013 PHRM 563 Women’s Health, Jefferson College of Pharmacy, Philadelphia PA

2013 GC 650 Economic Analysis of Healthcare Interventions, Jefferson Graduate School of Biomedical Sciences, Philadelphia PA

2008-2011 PH506: Health Services Research, Jefferson College of Population Health, Philadelphia PA

2002-2007 GC515: Quality Measurement and Outcomes Analysis, Jefferson College of Graduate Biomedical Sciences, Philadelphia PA

Mentoring Experience

2018 Capstone Advisor for Alex Cockerham and Brian Ung, Masters of Science in Health Outcomes, Policy, and Economics, Rutgers University

2017 Capstone Advisor for Joseph Guilfoyle, Rina Mehta, and Mary Smart, Masters of Science in Health Outcomes, Policy, and Economics, Rutgers University

2015 Thesis Advisor for Maura Bocan, Masters of Biomedical Sciences Program, Jefferson Graduate School of Biomedical Sciences, Philadelphia PA

2015 Preceptor for Lauren Karel PharmD, PGY2 Residency rotation in pharmacoeconomics research, Thomas Jefferson University Hospital, Philadelphia PA

2014 Capstone Project Advisor for David Winters, Masters of Biomedical Sciences Program, Jefferson Graduate School for Biomedical Sciences, Philadelphia PA

2013-2014 Faculty Mentor for Ginah Nightingale PharmD, American Society for Health Systems Pharmacy New Investigator Grant

2012-2013 Faculty Mentor for Ginah Nightingale PharmD, American Society for Health Systems Pharmacy Research Boot Camp and American Association of Colleges of Pharmacy New Investigator Grant

2012-2013 Capstone Project Advisor for Camila Zangalli MD, Masters of Public Health Program, Jefferson School of Population Health, Philadelphia PA

2012-2013 Capstone Project Advisor for Jason Schafer PharmD, Masters of Public Health Program, Jefferson School of Population Health, Philadelphia PA

2010-2011 Capstone Project Advisor for Neil Seligman MD, Masters of Public Health Program, Jefferson School of Population Health, Philadelphia PA

Laura T. Pizzi Page 5

2010-2011 Preceptor, Introductory Pharmacy Practice Experiences in Pharmacoeconomics, Jefferson College of Pharmacy, Philadelphia PA

2003-06; 2009-10 Fellowship Director, Department of Health Policy, Jefferson Medical College, Philadelphia PA

2007-2010 Preceptor, Advanced Pharmacy Practice Experience in Pharmacoeconomics, University of the Sciences, Philadelphia PA

Bibliography:

Research Publications, Peer-Reviewed

1. Padidam S, Wisner D, Kenney B, Peterson J, Pizzi L, Leiby BE, Hark L, Bailey R, Wills Cataract Research Group. Cataract Surgery Cancellations: An Analysis of Financial and Resident Training Implications at a Major Eye Institution. Journal of Academic Ophthalmology 2018 Jan;10(01):e1-4.

2. Nightingale G, Hajjar E, Pizzi LT, Wang M, Pigott E, Doherty S, Prioli KM, Swartz K, Chapman AE. Implementing a pharmacist-led, individualized medication assessment and planning (iMAP) intervention to reduce medication related problems among older adults with cancer. Journal of Geriatric Oncology 2017 Jul 1;8(4):296-302.

3. Nightingale G, Pizzi LT, Barlow A, Barlow B, Jacisin T, McGuire M, Swartz K, Chapman A. The prevalence of major drug-drug interactions in older adults with cancer and the role of clinical decision support software. Journal of Geriatric Oncology. 2018 Mar 3.

4. Prioli KM, Pizzi LT, Kash KM, Newberg AB, Morlino AM, Matthews MJ, Monti DA. Costs and effectiveness of mindfulness-based art therapy versus standard breast cancer support group for women with cancer. American Health & Drug Benefits 2017 Sep;10(6):288.

5. Hark LA, Katz LJ, Myers JS, Waisbourd M, Johnson D, Pizzi LT, Leiby BE, Fudemberg SJ, Mantravadi AV, Henderer JD, Zhan T. Philadelphia Telemedicine Glaucoma Detection and Follow-up Study: Methods and Screening Results. American Journal of Ophthalmology 2017 Sep 1;181:114-24.

6. Pizzi LT, Waisbourd M, Hark L, Sembhi H, Lee P, Crews JE, Saaddine JB, Steele D, Katz LJ. Costs of a community-based glaucoma detection programme: analysis of the Philadelphia Glaucoma Detection and Treatment Project. British Journal of Ophthalmology 2018 Feb 1;102(2):225-32.

7. Murchison AP, Hark L, Pizzi LT, Dai Y, Mayro EL, Storey PP, Leiby BE, Haller JA. Non-adherence to eye care in people with diabetes. BMJ Open Diabetes Research and Care. 2017;5(1):e000333.

8. Pizzi LT, Prioli KM, Fields Harris L, Cannon-Dang E, Marthol-Clark M, Alcusky M, McCoy M, Schafer JJ. Knowledge, Activation, and Costs of the Pharmacists’ Pneumonia Prevention Program (PPPP): A Novel Senior Center Model to Promote Vaccination. Annals of Pharmacotherapy. 2017 Nov 1:1060028017745566. Featured in: Pizzi LT. Novel approach to promote vaccination highly successful. PharmacoEconomics & Outcomes News 2017;793:22-16.

9. Fortinsky RH, Gitlin LN, Grady J, Piersol CV, Pizzi LT, Robison JT, Molony S. Translating the care of persons with dementia in their environments (COPE) intervention for use in publicly funded home care programs in the United States. Alzheimer's & Dementia: The

Laura T. Pizzi Page 6

Journal of the Alzheimer's Association 2016;12(7):P221.

10. Winters D, Casten R, Rovner B, Murchison A, Leiby BE, Haller JA, Hark L, Weiss DM, Pizzi LT. Cost-Effectiveness of Behavior Activation Versus Supportive Therapy on Adherence to Eye Exams in Older African Americans With Diabetes. American Journal of Medical Quality. 2016:1062860616680290.

11. Prioli KM, Pizzi LT, Karp JK, Galanis T, Herman JH. Cost of Purchased Versus Produced Plasma from Donor Recruitment Through Transfusion. Applied Health Economics and Health Policy 2016;14(5):609-17.

12. Gitlin LN, Piersol CV, Hodgson N, Marx K, Roth DL, Johnston D, Samus Q, Pizzi L, Jutkowitz E, Lyketsos CG. Reducing neuropsychiatric symptoms in persons with dementia and associated burden in family caregivers using tailored activities: Design and methods of a randomized clinical trial. Contemporary Clinical Trials 2016;49:92-102.

13. Hark L, Waisbourd M, Myers JS, Henderer J, Crews JE, Saaddine JB, Molineaux J, Johnson D, Sembhi H, Stratford S, Suleiman A, Pizzi L, Spaeth GL, Katz LJ. Improving Access to Eye Care among Persons at High-Risk of Glaucoma in Philadelphia — Design and Methodology: The Philadelphia Glaucoma Detection and Treatment Project. Ophthalmic Epidemiology 2016; 23(2); 122-30.

14. Fortinsky RH, Gitlin LN, Pizzi LT, Piersol CV, Grady J, Robison JT, Molony S. Translation of the Care of Persons with Dementia in their Environments (COPE) intervention in a publicly- funded home care context: Rationale and research design. Contemporary Clinical Trials 2016;49:155-65.

15. Pizzi LT, Tran J, Shafa A, Waisbourd M, Hark L, Murchison AP, Dai Y, Mayro EL, Haller JA. Effectiveness and Cost of a Personalized Reminder Intervention to Improve Adherence to Glaucoma Care. Applied Health Economics and Health Policy 2016; online ahead of print Feb 29:1-2. DOI:10.1007/s40258-016-0231-8

16. Waisbourd M, Shafa A, Delvadia R, Sembhi H, Molineaux J, Henderer J, Pizzi LT, Myers JS, Hark LA, Katz LJ. Bilateral Same-day Laser Peripheral Iridotomy in the Philadelphia Glaucoma Detection and Treatment Project. Journal of Glaucoma 2016; online ahead of print Mar 4. DOI: 10.1097/IJG.0000000000000409

17. Hark L, Waisbourd M, Myers JS, Henderer J, Crews JE, Saaddine JB, Molineaux J, Johnson D, Sembhi H, Stratford S, Suleiman A, Pizzi L, Spaeth GL, Katz LJ. Improving Access to Eye Care among Persons at High-Risk of Glaucoma in Philadelphia—Design and Methodology: The Philadelphia Glaucoma Detection and Treatment Project. Ophthalmic Epidemiology 2016; online ahead of print Mar 7. DOI: 10.3109/09286586.2015.1099683

18. Zangalli CS, Murchison AP, Hale N, Hark LA, Pizzi LT, Dai Y, Haller JA. An education-and telephone-based intervention to improve follow-up to vision care in pa++tients with diabetes: a prospective, single-blinded, randomized trial. American Journal of Medical Quality 2016 31: 156-161. DOI:10.1177/1062860614552670

19. Storey PP, Murchison AP, Pizzi LT, Hark LA, Dai Y, Leiby BE and Haller JA. Impact of physician communication on diabetic eye care adherence: Results from a retrospective cohort analysis. Retina 2015; 36(1):20-7. DOI: 10.1097/IAE.0000000000000652

20. Schafer JJ, Green J, Pizzi LT and DiSimone J. The effects of a pharmacist-delivered patient education program on retention in HIV care: a pilot study. Journal of Pharmaceutical Health Services Research 2015;6(2):83–89. DOI: 10.1111/jphs.12092

21. Pizzi LT, Zangalli C, Murchison AP, Hale N, Hark LA, Dai Y, Leiby B, Haller JA. Cost effectiveness of an educational and telephone-based intervention to improve follow-up to

Laura T. Pizzi Page 7

vision care in patients with diabetes: decision analytic model based on a prospective, single- blinded, randomized trial. Applied Health Economics and Health Policy 2015:13(2); 253-263. DOI 10.1007/s40258-015-0159-4

22. Pizzi LT, Snitzer M, Amos T, Prioli K, Steele D, and Levin AV. Cost and effectiveness of an eye care adherence program for Philadelphia school children with significant visual impairment. Population Health Management. E-pub ahead of print Feb 3, 2015. DOI:10.1089/pop.2014.0090.

23. Pizzi LT, Jutkowitz E, Frick K, Suh DC, Prioli KM, and Gitlin LN for the Beat the Blues Study Team. Cost-effectiveness of a home-based non-pharmacological depression intervention for older African Americans: results from the beat the blues randomized trial. Journal of the American Geriatrics Society 2014:62(12);2288–2295. DOI: 10.1111/jgs.13146

24. Jutkowitz E, Choi HK, Pizzi LT, Kuntz KM. Cost-effectiveness of allopurinol and febuxostat for the management of gout. Annals of Internal Medicine 2014;161(9): 617-626.

25. Zanolli MT, Khetan V, Dotan G, Pizzi LT, Levin AV. Should patients with ocular genetic disorders have genetic testing? Current Opinion in Ophthalmology. 2014;25(5):359-365.

26. Pizzi LT, Seligman NS, Baxter JK, Jutkowitz E, and Berghella V. Cost and cost- effectiveness of vaginal progesterone gel in reducing preterm birth: an economic analysis of the PREGNANT trial. PharmacoEconomics 2014;32:467–478. DOI: 10.1007/s40273-014- 0133-2

27. Storey P, Murchison AP, Dai Y, Hark L, Pizzi LT, Leiby BE, Haller JA. Comparing methodologies for imputing ethnicity in an urban ophthalmology clinic. Ophthalmic Epidemiology 2014; 21(2):106-110. DOI:10.3109/09286586.2014.884603

28. Modersitzki F, Pizzi LT, Grasso M, Goldfarb DS. Health-related quality of life (HRQoL) in cystine compared with non-cystine stone formers. Urolithiasis 2014; 42(1): 53-60. DOI 10.1007/s00240-013-0621-4

29. Thoma BN, Li J, McDaniel C, Wordell CJ, Cavarocchi N, Pizzi LT. Clinical and economic implications of substituting dexmedetomidine for propofol in patients undergoing coronary artery bypass graft surgery. PharmacoEconomics 2014;32(2):149-57. DOI: 10.1007/s40273- 013-0116-8

30. Law M, Komura S, Pizzi LT, Hark L, and Murchison A. Pharmacy staff opinions regarding diabetic retinopathy screenings in the community setting: findings from a brief survey. American Health and Drug Benefits 2013;6(9):548-552.

31. Gitlin LN, Fields Harris L, McCoy M, Chernett NL, Pizzi LT, Jutkowitz E, Hess E, Hauck W. A home-based intervention to reduce depressive symptoms and improve quality of life in older African Americans: a randomized trial. Annals of Internal Medicine 2013:159(4):243- 52. DOI: 10.7326/0003-4819-159-4-201308200-00005

32. Hvisdas C, Lordan A, Pizzi LT, Thoma BN. US Propofol Drug shortages: a review of the problem and stakeholder analysis. American Health and Drug Benefits 2013;6(4):171-5.

33. Jutkowitz E, Pizzi LT, Hess E, Suh DC, Gitlin LN. Comparison of EQ-5D and HUI2-3 derived societal health state values among older African Americans with depression participating in the Beat the Blues trial. Quality of Life Research 2012. DOI: 10.1007/s11136-012-0263-y.

34. Pizzi LT, Toner R, Foley K, Thomson E, Chow W, Kim M, Couto J, Royo M, and Viscusi E.

Laura T. Pizzi Page 8

Relationship between potential opioid-related adverse effects and hospital length of stay in patients receiving opioids after orthopedic surgery. Pharmacotherapy 2012 June;32(6):502- 14.

35. Gitlin LN Fields-Harris L, McCoy M, Chernett N, Jutkowitz E, Pizzi LT and the Beat the Blues Team. A community-integrated home-based depression intervention for older African Americans: description of the Beat the Blues randomized trial and intervention costs. BMC Geriatrics 2012, 12(4). doi:10.1186/1471-2318-12-4, published online ahead of print at: http://www.biomedcentral.com/1471-2318/12/4/about

36. Shen X, Zaorsky NG, Mishra MV, Foley KA, Hyslop T, Hegarty S, Pizzi LT, Dicker AP, Showalter TN. Comparative effectiveness research for prostate cancer radiation therapy: Current status and future directions. Future Oncology 2012 Jan;8(1):37-54.

37. Jutkowitz E, Gitlin LN, Pizzi LT, Lee E, Dennis MP Cost-effectiveness of a home-based intervention that helps functionally vulnerable older adults age in place at home. Journal of Aging Research 2012, doi:10.1155/2012/680265

38. Showalter TN, Ohri N, Teti KG, Foley KA, Keith SW, Trabulsi EJ, Lallas CD, Dicker AP, Hoffman-Censits J, Pizzi LT, Gomella LG. Physician beliefs and practices for adjuvant and salvage radiation therapy after prostatectomy. International Journal of Radiation Oncology Biology and Physics 2012;82(2):e233-8. Epub 2011 May 24.

39. Meltzer M, Pizzi LT, Jutkowitz E. Payer decision-making with limited comparative and cost effectiveness data: The case of new pharmacological treatments for gout. Evidence Based Medicine 2012;17(4):105-8. doi: 10.1136/ebmed-2011-100065.

40. Showalter TN, Foley KA, Jutkowitz E, Lallas CD, Trabulsi EJ, Gomella LG, Dicker AP, and Pizzi LT. Costs of early adjuvant radiation therapy after radical prostatectomy: a decision analysis. Annals of Oncology 2011; 23(3) 701-706. doi: 10.1093/annonc/mdr281

41. Toner RW, Pizzi L, Leas B, Ballas SK, Quigley A, and Goldfarb N. Cost of blood in the

United States. Applied Health Economics and Health Policy 2011 9(1): 29-37.

42. Pizzi LT, Gravino DA, Suh K. Diabetes quality measurement: a primer for pharmacists. American Journal of Pharmaceutical Benefits 2011; 3(1): 63-7.

43. Lee E, Jutkowitz E, Pizzi LT, Casey DE. Use of a case study format to develop physicians’ comparative effectiveness interpretive skills: experiences from a workshop featuring the ICER report on management options for low-risk prostate cancer. American Journal of Medical Quality 2010;25(6):481-85.

44. Jutkowitz E, Gitlin L, Pizzi LT. Evaluating willingness to pay thresholds for dementia caregiving interventions: application to the tailored activity program. Value in Health 2010:13(6); 720–725.

45. Sclafani AP, Pizzi LT, Jutkowitz E, Mueller N, Jung M. FILLERS-Q: an instrument for assessing patient experiences after treatment with facial injectable soft tissue fillers. Facial Plastic Surgery 2010; 26: 310-9.

46. Gitlin LN, Hodgson N, Jutkowitz E, Pizzi LT. The cost-effectiveness of a non-pharmacologic intervention for individuals with dementia and family caregivers: the Tailored Activity Program. American Journal of Geriatric Psychiatry 2010 June;18(6):510-9.

47. Abouzaid SA, Jutkowitz E, Foley KA, Pizzi LT, Kim E, Bates J. Economic impact of prior authorization policies for atypical antipsychotics in the treatment of schizophrenia. Population Health Management 2010 Oct;13(5):247-54.

48. Pizzi LT, Talati A, Gemmen E, Dahl NV, Bunz TJ, and Sand P. Impact of transdermal

Laura T. Pizzi Page 9

oxybutynin on work productivity in patients with overactive bladder: results from the MATRIX study. PharmacoEconomics 2009; 27(6): 329-39.

49. Pizzi LT, Bunz TJ, Coyne DW, Goldfarb DS, Singh AK. Ferric gluconate yields cost-savings in hemodialysis patients with high ferritin and low TSAT: results from the DRIVE studies. Kidney International 2008; 74: 1588–1595. (also featured in the editorial by Eisenstein: DRIVE it home: Making the case for prospective economic data collection in randomized clinical trials. Kidney International 2008;74(12):1507-1509.

50. Hayes E, Moroz L, Pizzi L, Baxter J. A cost decision analysis of four tocolytic drugs. American Journal of Obstetrics & Gynecology 2007;197(4): 383-383.

51. Lofland JH, Gagne JJ, Pizzi LT, Rupnow M, Silberstein SD. Impact of topiramate migraine prophylaxis on workplace productivity: results from two US randomized, double-blind, placebo-controlled, multicenter trials. Journal of Environmental and Occupational Medicine 2007 Mar;49(3):252-7.

52. Pizzi LT, Patel NM, Maio VM, Goldfarb D, Michael B, Fuhr JP, and Goldfarb NI. Economic implications of non-adherence to treatment recommendations for hemodialysis patients with anemia. Dialysis and Transplantation 2006; 35(11):660-671.

53. Pizzi LT, Weston CM, Goldfarb NI, Moretti D, Cobb N, Howell JB, Infantolino A, DiMarino AJ, Cohen S. Impact of Chronic Conditions on Quality of Life in Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2006;12(1):47-52.

54. Salvador CG, Sikirica M, Evans A, Pizzi L, and Goldfarb N. Clinical and economic outcomes of prolonged postoperative ileus in patients undergoing hysterectomy and hemicolectomy. P&T 2005; 30(10): 590-5.

55. Roumm A, Pizzi LT, Goldfarb NI, Cohn H. Minimally invasive: minimally reimbursed? An examination of six laparoscopic surgical procedures. Surgical Innovation 2005; 12(3):261- 88.

56. Pizzi LT, Carter CC, Howell JB, Vallow SM, Crawford AG, Frank ED. Work Loss and Healthcare Utilization among U.S. Employees with Chronic Non-Cancer Pain. Disease Management and Health Outcomes 2005; 13(3):201-8.

57. Maio V, Pizzi L, Roumm AR, Clarke J, Goldfarb NI, Nash DB, and Chess D. Pharmacy utilization and the Medicare Modernization Act. The Milbank Quarterly 2005;83(1):101-30.

58. Pizzi LT, Suh DC, Barone J, and Nash DB. Factors related to physicians’ adoption of electronic prescribing: Results of a national survey. American Journal of Medical Quality 2005; 20(1):22-32.

59. Goldfarb NI, Pizzi LT, Fuhr JP, Salvador C, Sikirica V, Kornbluth A, and Lewis B. Diagnosing Crohn’s disease: an economic analysis comparing wireless capsule endoscopy with traditional diagnostic procedures. Disease Management 2004;7(4):292-304.

60. Pizzi LT, Howell JB, Deshmukh A, Cohen H, and Nash, DB. Clinical information management systems: an emerging data technology for inpatient pharmacies. American Journal of Health-System Pharmacy 2004;61:76-81.

61. Goldfarb NI, Maio V, Carter CT, Pizzi L, and Nash DB. How does quality enter into healthcare purchasing decisions? The Commonwealth Fund Issue Brief, May 2003.

62. Loeppke R, Hymel PA, Lofland JH, Pizzi LT, Konicki DL, Anstadt GW, Baase C, Fortuna J, Scharf T, on behalf of the members of the American College of Occupational and

Laura T. Pizzi Page 10

Environmental Medicine Expert Panel. Health-related workplace productivity measurement: General and migraine specific recommendations from the ACOEM expert panel. Journal of Occupational and Environmental Medicine 2003;45(4):349-59.

63. Pizzi LT, Menz JM, Graber GG, and Suh DC. From product-dispensing to patient-care: the role of the pharmacist in providing pharmaceutical care as part of an integrated disease management approach. Disease Management 2001; 4(4):143-54.

64. Pizzi LT, Biskupiak J. Impact of compliance on treatment outcomes. Disease Management and Health Outcomes 1999;6(5):269-278.

Editorials and Reviews, including participation in committee reports:

1. McRae J, Vogenberg FR, Beaty SW, Mearns E, Varga S, Pizzi L. A Review of US Drug Costs Relevant to Medicare, Medicaid, and Commercial Insurers Post-Affordable Care Act Enactment, 2010–2016. PharmacoEconomics 2016 Oct 31:1-9.

2. Pizzi LT. The Institute for Clinical and Economic Review and Its Growing Influence on US Healthcare. American Health and Drug Benefits 2016:9(1);9-10.

3. Joshi K, Murchison AP, Leiby BE, and Pizzi LT. The unmet eye care needs in diabetic patients on hemodialysis. Population Health Matters 2015:28(2),11.

4. Fulginiti J, Schafer JJ, Marthol-Clark M; Fields Harris L, DeSimone J, and Pizzi LT. Pharmacists on the front lines of community health: the pneumonia prevention project. Population Health Matters 2014:27(4),4.

5. Leon J, Pizzi LT, and Steele D. Teaching US healthcare organization and delivery: two models of instruction. Population Health Matters 2014:27(3),3.

6. Mearns E, Pizzi LT, Baxter J, and Berghella V. Preterm birth and the controversy over universal cervical length screenings. Population Health Matters 2013:26(2);4.

7. Pizzi LT. Tightening our belts in the new healthcare economy. Population Health Matters 2013:26(1);1.

8. McMahon J, Schaefer E, Pizzi L, Thomson E. Evaluation of phase I demonstrations of the pharmacy quality alliance. Report to the Agency for Healthcare Research and Quality Center for Quality and Patient Safety (Contract # HHSA290200600014, Task Order # 2), August 31 2010.

9. Pizzi LT, Sclafani AP. Reflections on cost and outcomes in facial plastic surgery: five reasons to measure value. Facial Plastic Surgery 2010; 26:275-8.

10. Pizzi LT. Dare to compare. Health Policy Newsletter 2009; 22(3).

11. Pizzi LT. Economic considerations in a changing anemia environment. (Commentary). American Journal of Kidney Disease 2008; 52(6): S29-S33

12. Pizzi LT and Singh VP. Pharmacoeconomics is coming of age. Clinical Pharmacology and Therapeutics 2008; 84(2): 188–190.

13. Bunz TJ and Pizzi LT. Challenges and benefits in using productivity data from clinical trials

for value-based purchasing decisions. Value Based Purchasing 2008; 2(2)

14. Nash DB, Pizzi LT, and Chaudhari P. Evidence on the evidence. MedPage Today. February 11, 2008.

15. Pizzi LT and Bunz TJ. Anemia in chronic kidney disease: an opportunity and challenge for disease management (Commentary). Disease Management 2008: 11(1): 47-48.

Laura T. Pizzi Page 11

16. Pizzi LT, Gagne JJ, Smith KD. Pills and productivity: what economic theory tells us about the impact of pharmaceuticals on work function. ISPOR Connections 2006;12(6): 7-8.

17. Pizzi LT and Goldfarb NI. Literature review. American Journal of Medical Quality 2006;21(2):148-50.

18. Pizzi LT. Department of health policy fellowship programs: A tradition of excellence. Health Policy Newsletter 2005;18(4):7.

19. Lofland JH, Pizzi LT, and Fricke K. A review of health-related workplace productivity loss instruments. Pharmacoeconomics 2004; 22(3):165-84.

Books or Book Chapters:

1. Pizzi LT. Health technology assessment. In: Fulda T, Lyles A, and Wertheimer (eds.). Pharmaceutical public policy. Boca Raton, FL: CRC Press, 2016.

2. Pizzi LT, Jutkowitz E, and Nyman J. Cost Analysis of Behavioral Interventions. In: Gitlin LN and Czaja SJ (eds.). Behavioral intervention research: Designing, evaluating, and implementing. New York, NY: Springer Publishing Company, 2015.

3. Pizzi LT and Lofland JL (eds). Economic evaluation in U.S. healthcare: principles and applications. Sudbury, MA: Jones and Bartlett, 2006.

4. Pizzi LT, Howell JH, Lofland JH. The role of the pharmacist in disease management. In: Petersen AM (ed). Managing pharmacy practice: principles, strategies, and systems. Boca Raton, Florida: CRC Press, 2004.

5. Pizzi LT, Goldfarb N, Nash DB. Chapter 40. Promoting a culture of safety, Chapter 44. Crew resource management and its applications in medicine, Chapter 48. Procedures for obtaining informed consent, Chapter 50. Other practices related to patient participation. In: Making health care safer: a critical analysis of patient safety practices. Shojania KG, Duncan BW, McDonald KM, Wachter RM, editors. Evidence Report/Technology Assessment No. 43, AHRQ Publication No. 01-E058; July 2001.

6. Toscani MT and Pizzi LT. Measuring and improving the intervention. In: Patterson R and Demak-Epstein M, eds. Changing Patient Behavior. Chicago: AHA Press, 2000.

Research Podium or Poster Presentations, Peer-Reviewed:

1. Pizzi L, Jutkowitz E, Prioli K, Gitlin LN, Fortinsky R. COPE-CT Intervention Costs and Willingness to Pay Analysis: Interim Findings. International Association for Geriatrics and Gerontology Conference, San Francisco CA, July 2017.

2. Prioli KM, Schafer JJ, Pizzi LT. Reducing Disparities in US Vaccination through Senior Centers: A Comparison of Three Education Models for Older African Americans. Poster

presentation at the ISPOR 19th Annual European Congress, Vienna Austria, November 2016.

3. Prioli KM, Lyons NM, Pizzi LT. Tasks Involved in Platelet Production and Transfusion from The U.S. Hospital Perspective: Two Process Frameworks. Poster presentation at the ISPOR 19th Annual European Congress, Vienna Austria, November 2016.

4. Pizzi L, Jutkowitz E, Prioli K, Gitlin L, Fortinsky RH. Cost Analysis Plan and Caregivers Willingness to Pay for COPE-CT: Interim Findings. Symposium presentation at the Gerontological Society of America Annual Meeting, New Orleans LA, November 2016.

Laura T. Pizzi Page 12

5. Pizzi L, Jutkowitz E, Marx K, Gitlin L. What are Family Caregivers Willing to Pay for an Intervention to Address Behavioral Symptoms? Symposium presentation at the Gerontological Society of America Annual Meeting, New Orleans LA, November 2016.

6. Pizzi LT, Prioli K, Seidner M, Cunningham C, Ollendorf D. How Stakeholders are Responding to ICER Drug Therapy Reports: An Analysis of Public Comments. Poster presentation at the ISPOR 21st Annual International Meeting, Washington DC, May 2016.

7. Varga S, Prioli K, Gitlin LN, Jutkowitz E, Pizzi LT. Developing Consistent Measures for Cost Analyses of Dementia Behavioral Trials: A Review of Four Study Protocols. Poster presentation at the ISPOR 21st Annual International Meeting, Washington DC, May 2016.

8. McRae J, Prioli K, Schafer JJ, Cannon-Dang E, Harris LF, Pizzi LT. Developing Beliefs that Support Vaccination: Results from the Pharmacists’ Pneumonia Prevention Program. Poster presentation at the ISPOR 21st Annual International Meeting, Washington DC, May 2016.

9. Dally TM, Prioli K, Leiby BE, Murchison AP, Michael B, Brahmbhatt Y, Pizzi LT. Satisfaction with Pharmacy Services in Diabetic Dialysis Patients Enrolled in an Eye Care Study at Two Centers. Poster presentation at the ISPOR 21st Annual International Meeting, Washington DC, May 2016

10. Kanaskar A, McRae J, Mintzer S, Pizzi LT. What is Reported in Cost Effectiveness Analyses of Antiepileptics? A Descriptive Analysis using the CHEERS Criteria. Poster presentation at the ISPOR 21st Annual International Meeting, Washington DC, May 2016.

11. Mayro EL, Murchison AP, Hark LA, Dai Y, Leiby BE, Pizzi LT, Haller JA. Depression screening in an urban, ophthalmic office: prevalence and associated factors. Presentation at the the Association for Research in Vision and Opthalmology (ARVO) Annual Meeting, Powerful Connections: Vision Research and Online Networking, May 3-7 2015, Denver, Colorado.

12. Alcusky MJ, Cannon-Dang E, Steele D, Schafer JJ, DeSimone Jr. JA, Pizzi LT. Cost of a pharmacist-led pneumonia education and immunization program for older Philadelphians. Poster presentation at the ISPOR 20th Annual International Meeting, May 16-20 2015 Philadelphia, PA.

13. Schafer JJ, Steele D, Marthol MM, Harris LF, Pizzi LT. Knowledge gaps about pneumonia in older adults: results from the pharmacists’ pneumonia prevention project. Poster presentation at the ISPOR 20th Annual International Meeting, May 16-20, 2015 Philadelphia, PA.

14. Pizzi LT, Steele D, Sembhi H, Hark L, Waisbourd M, Katz LJ. Cost analysis of the Philadelphia glaucoma community detection and treatment project. Poster presentation at the ISPOR 20th Annual International Meeting, May 16-20, 2015 Philadelphia, PA.

15. Pizzi LT, Karel L, Shang T, Casten RJ, Rovner BW. Antidepressant use in patients with age-related macular degeneration and depressive symptoms: results from the low vision depression prevention trial. Poster presentation at the ISPOR 20th Annual International Meeting, May 16-20, 2015 Philadelphia, PA.

16. Cannon-Dang E, Murchison AP, Bilyk JR, Pizzi LT. Cost of canalicular laceration repair in different hospital settings: a decision analysis. Poster presentation at the ISPOR 20th Annual International Meeting, May 16-20, 2015 Philadelphia, PA. (poster finalist ribbon)

17. Pizzi LT, Zangalli C, Murchison AP, Hale N, Hark L, Dai Y, Leiby BE, Haller JA.

Laura T. Pizzi Page 13

Comparative effectiveness and costs of strategies to improve follow-up for diabetic eye care visits. Poster presentation at the International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting, June 2014, Montreal Canada.

18. Amos T, Snitzer M, Pizzi LT, Levin A. Cost and effectiveness of an eye care adherence program for school children with significant visual impairment. Poster presentation at the International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting, June 2014, Montreal Canada.

19. Cannon-Dang E, Schafer JJ, Steele D, Pizzi LT. Pharmacist vaccination programs for common infectious diseases: a systematic review of the literature on this emerging model of care. Poster presentation at the International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting, June 2014, Montreal Canada.

20. Pizzi LT, Morlino A, Kash KM, Newberg A, Matthews MJ, Monti D. Comparative costs and effectiveness of mindfulness-based art therapy to usual support for women with cancer: results from a randomized clinical trial. Poster presentation at the International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting, June 2014, Montreal Canada.

21. Pizzi LT and Kash KM. Evidence from an Economic Analysis of a Clinical Trial: Mindfulness- Based Art Therapy Program for Women with Breast Cancer. American Psychosocial Oncology Society 11th Annual Conference, Tampa FL, February 2014

22. Zangalli C, Hale N, Dai Y, Leiby B, Pizzi LT, Hark LA, Murchison AP, Haller JA. Effectiveness of a clinic-based intervention to improve follow-up adherence to vision care in patients with diabetes. Poster presentation at the 141st American Public Health Association Annual Meeting and Exposition, Boston Massachusetts, November 2013

23. Murchison AP, Dai Y, Leiby B, Hark LA, Pizzi LT, Haller JA. Predictors of eye care utilization in patients with diabetes: a retrospective analysis from a tertiary care center. Poster presentation at the 141st American Public Health Association Annual Meeting and Exposition, Boston Massachusetts, November 2013.

24. Storey P, Dai Y, Murchison AP, Pizzi LT, Hark LA, Leiby B, Haller JA. Best practices for analyzing real-world data: Comparing methodologies for imputing ethnicity in a high volume urban clinic. Poster presentation at the 141st American Public Health Association Annual Meeting and Exposition, Boston Massachusetts, November 2013

25. Pizzi LT, Karp JK, Galanis P, Prioli KM, Herman JH. Comprehensive cost analysis of fresh frozen plasma in an urban hospital setting: an observational and decision analysis. Poster presentation at the AABB Annual Meeting, Denver Colorado, October 2013. (top poster award)

26. Pizzi LT, Seligman N, Jutkowitz E, Prioli K, Baxter J, and Berghella V. Cost-effectiveness of vaginal progesterone gel in reducing preterm birth: a decision analytic model based on the PREGNANT randomized clinical trial. Poster presentation at the 18th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research, New Orleans, Louisiana, May 2013.

27. Pizzi LT, Jutkowitz E, Frick K, Suh D, Prioli K, Gitlin L. Healthcare and social service use and cost in depressed African American elders: results from the Beat the Blues randomized clinical trial. Poster presentation at the 18th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research, New Orleans, Louisiana, May 2013.

Laura T. Pizzi Page 14

28. Prioli K, Schafer J, Fields Harris L, McCoy M, Barber E, Marthol-Clark M, Pizzi LT. Awareness and beliefs about pneumococcal and influenza vaccination among older African Americans: results from a survey of community-dwelling participants at an urban senior center. Poster presentation at the 18th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research, New Orleans, Louisiana, May 2013.

29. Levin A, Pizzi LT, Snitzer M, Prioli K. Barriers to follow up care in children with vision diseases: development of a conceptual framework and patient/caregiver survey through the Children’s Eye Care Adherence Project. Poster presentation at the 18th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research, New Orleans, Louisiana, May 2013.

30. Tan WP, Fong ZV, Cowan SW, Evans SW, Keith SW, Pizzi LT, Berger AC, Chojnacki A, Palazzo F, Yeo CJ, Rosato EL. Laparoscopic versus open esophagectomy: a clinical and cost-effectiveness study. Poster presentation at the Southern Surgical Association Annual Meeting, Palm Beach Florida, December 2012.

31. Thoma BN, Li J, McDaniel C, Wordell CJ, Pizzi LT, Cavarocchi N. Clinical and economic implications of substituting dexmedetomidine for propofol or midazolam in patients undergoing coronary artery bypass graft surgery. Poster presentation at the Society of

Critical Care Meeting 42nd Critical Care Congress, San Juan Puerto Rico, January 2013.

32. Li J, Thomas B, Wordell C, Pizzi LT, Cavarocchi N. Cost-benefit of substituting dexmedetomidine for propofol in patients undergoing isolated, elective coronary artery

bypass graft surgery. Poster presentation at the 47th Annual ASHP Midyear Clinical Meeting, Las Vegas Nevada, December 2012.

33. Li J, McDaniel C, Thoma B, Wordell C, Pizzi LT, Mearns E, Cavarocchi N. Clinical and economic implications of substituting dexmedetomidine for propofol in patients during a recent national drug shortage: examination of hospital patients undergoing uncomplicated coronary artery bypass graft (CABG) surgery. Poster presentation at the Challenges in Critical Care Conference (PASCCM), Hershey Pennsylvania, August 2012. (Best Poster Award)

34. Pizzi LT, Jutkowitz E, Frick K, Suh DC, Prioli KM, Gitlin LN. Novel approaches to evaluating the cost effectiveness of a nonpharmacological depression intervention for older African Americans: results from the Beat the Blues Trial. Late breaker poster at the Gerontology Society of America Annual Meeting, San Diego California, November 2012.

35. Gitlin LN, Harris LF, McCoy M, Jutkowitz E, Pizzi LT, Wilson N. Closing the mental health disparity gap for older African Americans: the Beat the Blues Trial session. Research symposium presentation at the Gerontology Society of America Annual Meeting, San Diego California, November 2012.

36. Murchison AP, Dai Y, Leiby B, Hark LA, Pizzi LT, and Haller JA. Eye care utilization by patients with diabetes: a retrospective analysis targeted to improve follow-up adherence.

Session presentation at the American Public Health Association 140th Annual Meeting and Expo, San Francisco California, October 2012.

37. Schaefer E, McMahon J, Pizzi L. Laying the groundwork for pharmacy quality measurement: evaluating the implementation of pharmacy performance reports. Poster presentation at the Academy Health Annual Research Meeting, Orlando Florida, June 2012.

38. Komura S, Law M, Hark LA, Murchison AP, Pizzi LT. Tele-ophthalmology in the community pharmacy setting: a novel model of care. Poster presentation at the International

Laura T. Pizzi Page 15

Pharmaceutical Students Federation (IPSF) 58th Annual World Congress, Hurghada, Egypt, August 2012.

39. Pizzi LT, Jutkowitz E, Law M, Komura S, Gitlin L. Utility improvements from a depression home support program for older African Americans: results from the Beat the Blues trial. Poster presentation at the International Society for Pharmacoeconomics and Outcomes

Research (ISPOR) 17th Annual Meeting, June 2012.

40. Murchison A, Hark LA, Haller JA, Malunda JA, Leiby B, Dai Y, Pizzi L. Access to eye care by patients with diabetes: a retrospective analysis. Research symposium presentation at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, Fort Lauderdale Florida, May 2012.

41. Pizzi LT, Jutkowitz E, Gitlin LN, Suh DC. Predictors of health utility in depressed older African Americans: Beat the Blues Trial results. Poster Presentation at the Gerontological Society of America's 64th Annual Scientific Meeting, Boston Massachusetts, November 2011.

42. Pizzi LT, Thomson L, Jutkowitz E, Vogenberg FR, Swift B, Merli G. Development of an economic model to improve the efficiency of anticoagulation care: experiences from a large urban U.S. academic health system. Decision Maker Case Study Presentation at the ISPOR

14th Annual European Congress, Madrid Spain, November 2011.

43. Pizzi LT, Thomson L, Jutkowitz E, Vogenberg FR, Swift B, Merli G. Development of an institutional cost of care model for anticoagulation management of patients with warfarin

versus novel oral agents. Poster Presentation at the ISPOR 14th Annual European Congress, Madrid Spain, November 2011.

44. Yuen EJ, Dai Y, Leiby B, Pizzi L, Hark L, Murchison A, Haller J. A retrospective analysis using administrative data of factors that impact access to vision care for patients with diabetes. Oral Presentation on The INSIGHT Research Network: a new collaborative approach to strategies for improving population eye health. the American Public Health Association 139th Annual Meeting, Washington DC, November 2011.

45. Teti KG, Ohri N, Foley KA, Keith SW, Dicker AP, Pizzi LT, Gomella LG, Showalter TN. A Survey of Post-prostatectomy Radiation Therapy Practices for Prostate Cancer: Postoperative Utilization of IMRT and IGRT. Fuel and Energy Abstracts 10/2011; 81(2). DOI:10.1016/j.ijrobp.2011.06.724

46. Jutkowitz E, Gitlin L, Pizzi LT, Lee EH, and Dennis M. Cost-effectiveness of ABLE: a functional improvement program to decrease mortality in community-dwelling older

adults. Poster presentation at the ISPOR 16th Annual International Meeting, Baltimore Maryland, May 2011.

47. Pizzi LT, Jutkowitz E, Gitlin L, Suh DC, and Dennis M. Baseline results from Beat the Blues: relationship between health utility and depression. Poster presentation at the ISPOR

16th Annual International Meeting, Baltimore Maryland, May 2011.

48. Gravino DA, Pizzi LT, Thomson E. How should pharmacists be trained on quality? Findings from the evaluation of the Pharmacy Quality Alliance (PQA) phase I

demonstration project. Poster presentation at the 45th ASHP Midyear Clinical Meeting, Anaheim California, December 2010.

49. Jutkowitz E, Pizzi LT, Gitlin L, Foley K, Chernett N, McCoy M, Dennis M. Costs of a community support program for depression: results from the Beat the Blues (BTB) trial. Poster presentation at the ISPOR European Congress, Prague Czech Republic,

Laura T. Pizzi Page 16

November 2010.

50. Showalter TN, Foley KA, Jutkowitz E, Lallas C, Harvey AJ, Trabulsi EJ, Gomella LG, Dicker AP, Pizzi LT. Costs of early adjuvant radiation therapy after radical prostatectomy: a decision analysis. Oral presentation at the American Society for Radiation Oncology (ASTRO) Annual Meeting, San Diego California, October 2010.

51. Pizzi L, Jutkowitz E, Meltzer M. Comparison of cost of allopurinol vs. febuxostat as a first line treatment for gout. Poster presentation at the EULAR Annual Conference, Rome, Italy, June 2010.

52. Pizzi LT, Naik M, Abouzaid S, Lee E, Jutkowitz EA, Parasuraman S, and Derk C. Injection site reactions with subcutaneous anti-tnf treatments for rheumatoid arthritis: results from a pilot study at an urban teaching hospital. Published in meeting abstract book for the EULAR Annual Conference, Rome Italy, June 2010. (Poster finalist ribbon)

53. Jutkowitz E, Gitlin L, Pizzi LT. Evaluating willingness to pay thresholds for a dementia caregiving intervention. Podium presentation at the ISPOR 15th Annual International Meeting, Atlanta, Georgia, May 2010. (Best New Investigator Podium Presentation award)

54. Lee EH, Jutkowitz E, Parasuraman S, Derk C, Pizzi LT. Injection site reaction questionnaire: an adequate tool for measuring injection site reactions. Poster presentation at the ISPOR 15th Annual International Meeting, Atlanta Georgia, May 2010.

55. Pizzi LT, Lee EH, Thompson E, Berman B. Medication therapy quality: a review of measures and conceptual framework to align physicians and pharmacists. Poster presentation at the ISPOR 15th Annual International Meeting, Atlanta Georgia, May 2010.

56. Hagan M, Lee EH, Arikian S, Pizzi LT. Comparative effectiveness index: a conceptual approach to comparative effectiveness research. Poster presentation at the ISPOR 15th Annual International Meeting, Atlanta, Georgia, May 2010.

57. Abouzaid S, Jutkowitz E, Foley KA, Pizzi L, Bates J, Kim E. Economic impact of prior authorization policies for the atypical antipsychotic aripiprazole in the treatment of schizophrenia. Poster presentation at the American Psychiatric Association, Institute of Psychiatric Service (IPS) Annual Meeting, New York NY, October 2009.

58. Toner R, Whitesell E, Couto J, Kim M, Royo M, Pizzi LT, Viscusi E. Rate and Treatment of nausea and vomiting following orthopedic procedures: an analysis of four cohorts at an academic teaching institution. Poster presentation at the American Society of Anesthesiologists Annual Meeting, New Orleans Louisiana, October 2009.

59. Jutkowitz E, Gitlin LN, Pizzi LT, Bunz T. Dennis M. P. Cost-effectiveness of a functional program to increase quality of life in community-dwelling older adults. Presentation at the 19th International Association of Gerontology and Geriatrics, Paris France, July 2009.

60. Jutkowitz E, Gitlin LN, Hodgson N, Pizzi LT. The Cost-effectiveness of a nonpharmacologic intervention for individuals with dementia and family caregivers: the Tailored Activity Program. Poster at the International Conference on Alzheimer's Disease, Vienna Austria, June 2009.

61. Pizzi LT, Abouzaid S, Naik M, Cobb N, Buchanan J, Parasurman S. PMS26 Characteristics and health care utilization resulting from injection site reactions with anti-tnf

Laura T. Pizzi Page 17

treatments for rheumatoid arthritis: an analysis of cases at an urban teaching hospital. Poster presentation at the International Society of Pharmacoeconomics and Outcomes

Research for the 14th Annual Meeting, Orlando, Florida, May, 2009

62. Jutkowitz E, Singh V, Richardson D, Pizzi LT. The cost of chronic pain to society and payers of healthcare services. Poster presentation at the 5th World Congress of the World Institute of Pain, New York NY, March 2009.

63. Jutkowitz E, Gitlin LN, Pizzi LT, Bunz T, and Dennis MP. Cost-effectiveness of a functional program to increase quality of life in community-dwelling older adults. Poster presentation

at the Gerontological Society of America 61st Annual Scientific Meeting, Bar Harbor Maryland, November 2008.

64. Modersitzki F, Pizzi LT, and Goldfarb DS. Cystinuria causes worse health-related quality of life (HR-QoL) than non-cystine stones. Poster presentation at the American Society of Nephrology Renal Week, Philadelphia Pennsylvania, November 2008.

65. Chaudhari P, Richardson D, Singh V, Pizzi LT. Impact of nighttime pain on sleep quality in patients with chronic painful conditions. Poster presentation at the International Society of

Pharmacoeconomics and Outcomes Research for the 13th Annual Meeting, Toronto Canada, May 2008.

66. Liao D, Richardson D, Singh V, and Pizzi LT. Complementary and alternative medicine and healthcare utilization in patients with non-cancer chronic pain. Poster presentation at

the International Society of Pharmacoeconomics and Outcomes Research for the 13th

Annual Meeting, Toronto Canada, May 2008.

67. Pizzi LT, Lee SP, Richardson D, and the Breakthrough Pain Study Group. Resource utilization due to breakthrough pain: results from a prospective study on patients with chronic painful conditions. Poster presentation at the International Society for

Pharmacoeconomics and Outcomes Research 10th Annual European Congress, Dublin Ireland, October 2007.

68. Pizzi LT, Lee SP, Richardson D, and the Breakthrough Pain Study Group. Perception of breakthrough pain in patients with chronic painful conditions. Poster presentation at

the International Society for Pharmacoeconomics and Outcomes Research 10th Annual European Congress, Dublin Ireland, October 2007.

69. Pizzi LT, Bunz TJ, Goldfarb DS, Singh AK, and Coyne D. Ferric gluconate yields cost savings in hemodialysis patients with high ferritin and low TSAT: results from the DRIVE studies. Poster presentation at the American Society of Nephrology Renal Week, San Francisco California, November 2007.

70. Short J, Maio V, Pizzi LT. Evaluation of the impact of the Philadelphia community pharmacy network program. Poster presentation at the American Pharmaceutical Association (APhA) Annual Conference and Exposition. Atlanta Georgia, March 2007.

71. Pizzi LT, McIlwain M, Dahl NV. Safety of transdermal oxybutynin in the treatment of overactive bladder among patients using other transdermal medications: results of the MATRIX study. Poster presentation at the 108th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics (ASCPT). Anaheim California, March 2007.

72. Hayes E, Almario C, Pizzi LT, Kraft W, and Baxter J. Low molecular weight heparin, the most cost effective treatment of venous thromboembolism. Poster presentation at the

Society for Maternal Fetal Medicine (SMFM) 27th Annual Conference, San Francisco California, February 2007.

Laura T. Pizzi Page 18

73. Hayes E, Freehill N, Pizzi LT, Baxter J. Nifedipine is the most cost-effective tocolytic.

Poster presentation at the Society for Maternal Fetal Medicine (SMFM) 27th Annual Conference, San Francisco California, February 2007.

74. Hayes E, Almario C, Pizzi LT, Kraft W, BaxterJ. Low molecular weight heparin, the most cost effective treatment of venous thromboembolism. American Journal of Obstetrics and Gynecology 12/2006; 195(6). DOI:10.1016/j.ajog.2006.10.301

75. Hayes E, Moroz L, Pizzi LT, Freehill N, Baxter J. Nifedipine is the most cost effective tocolytic. American Journal of Obstetrics and Gynecology 12/2006; 195(6). DOI:10.1016/j.ajog.2006.10.847

76. Sand PK, Kelleher C, Pizzi LT, and Dahl NV. Effect of treatment for overactive bladder on work productivity: results from the MATRIX study. Poster presentation at the International

Urogynecological Association (IUGA) 31st Annual Meeting, Athens Greece, September 2006.

77. Pizzi LT, Gagne JJ, Lofland JH, Rupnow M, Smith KD, and Poston S. Effect of topiramate migraine prophylaxis on workplace productivity: results from two U.S. randomized, double- blind, placebo-controlled, multicenter trials. Poster presentation at the 48th Annual Scientific Meeting of the American Headache Society, Los Angeles California, June 2006.

78. Singh M, Pizzi LT, Lofland JL, Higashi M, and Patel N. Economic burden of work loss among sufferers of lymphatic filariasis: an eradicable global health problem. Podium

presentation at the 11th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Philadelphia Pennsylvania, May 2006.

79. Talati AR, Pizzi LT, Dahl N, and Gemmen E. Validation of the work productivity

questionnaire: results of the MATRIX study. Podium presentation at the 11th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Philadelphia Pennsylvania, May 2006.

80. Gagne JJ, Lofland JH, Rupnow M, Smith KD, Poston S, and Pizzi LT. Impact of topiramate for migraine prophylaxis on workplace productivity: results from two U.S. randomized,

double-blind, placebo-controlled, multicenter trials. Podium presentation at the 11th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Philadelphia Pennsylvania, May 2006.

Laura T. Pizzi Page 19

81. Talati AR, Pizzi LT, Dahl N, Gemmen E. Work productivity in patients with overactive bladder: Results from the MATRIX study. Value in Health 05/2006; 9(3). DOI:10.1016/S1098-3015(10)64613-X

82. Pizzi LT, Gemmen E, Dahl NV. Characteristics related to productivity loss in patients with

overactive bladder: results from the MATRIX study. Podium presentation at the 8th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research, Florence Italy, November 2005. (Best podium presentation)

83. Weston C, Poston S, Pizzi L, Goldfarb N, Sikirica V, Reifsnyder J, and Maxwell T. Opioid use in a large national hospice population: examination of cancer versus non-cancer

patients. Poster presentation at the 10th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Washington DC, May 2005.

84. Lofland JH, Rupnow M, Gagne JJ, Smith KD, Poston S, Pizzi LT, and Papadopoulos G. Impact of topiramate for migraine prophylaxis on workplace productivity: results from a U.S. randomized, double-blind, placebo-controlled, multicenter trial. Poster presentation at the American Academy of Neurology (AAN) Annual Meeting. San Diego California, April 2005.

85. Patel N, Goldfarb N, Hartmann CW, Maio V, Horn DL, and Pizzi L. Impact of complicated skin and soft tissue infections on inpatient costs for an academic medical center. Poster

presentation at the 10th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Washington DC, May 2005.

86. Salvador CG, Sikirica M, Evans A, Pizzi LT, Goldfarb NI. Clinical and economic outcomes of patients with prolonged postoperative ileus undergoing hysterectomy and hemicolectomy at an academic medical institution. Poster presentation at the American Society of Health- Systems Pharmacists Midyear Clinical Meeting, Orlando Florida, December 2004.

87. Goldfarb NI, Pizzi LT, Fuhr JP, Salvador C, Sikirica V, Kornbluth, A, and Lewis B. Role of wireless capsule endoscopy in the diagnosis of Crohn’s disease: an economic analysis. Poster Presentation at Digestive Disease Week, New Orleans Louisiana, May 2004.

88. Weston C, Sikirica V, Pizzi L, Goldfarb N, Moretti D, Cobb N, Howell J, Infantolino A, DiMarino A, Cohen S. Work Loss and Activity Impairment due to inflammatory bowel

disease. Podium presentation at the 9th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Crystal City Virginia, May 2004.

89. Chess D, Goldfarb NG, Pizzi LT. Impact of pharmaceutical utilization measures on seniors. American Society on Ageing Conference: Care Management in an Ageing Society, Philadelphia Pennsylvania, October 2003.

90. Pizzi LT, Johnson NE, Carter CT, Howell JB, Vallow SM, Frank ED. Work loss and healthcare utilization among U.S. employees with chronic non-cancer pain. Podium

presentation at the 8th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Crystal City Virginia, May 2003.

91. Belazi D, Crawford AG, Pizzi LT. Impact of direct to consumer advertising: the consumer search for information. Podium presentation at the 7th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Crystal City Virginia, May 2002.

92. Carter CC, Maio VM, Pizzi LT, Lofland JH, Lakhia P. Paving a road to success: how to obtain an outcomes research fellowship within the pharmaceutical industry. Podium

presentation at the 6th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Crystal City Virginia, May 2002.

Laura T. Pizzi Page 20

93. Parasuraman TV, Pizzi LT, Toscani MR, Coleman M, and Decker D. Telephony as a cost efficient method for assessing health care utilization and productivity loss in an employed

population. Poster presentation at the 7th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Crystal City Virginia, May 1999.

94. Parasuraman TV, Patterson R, Toscani MR, Coleman MJ, Pizzi LT. Influence of motivating factors and barriers on influenza vaccination in an employed population. Poster Presentation

at the 4th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Crystal City Virginia, May 1999.

95. Pizzi LT, Laskin MS, Gibson GA. Incidence and cost of IVIg-induced thromboembolic events. Platform presentation at the American Society of Health-System Pharmacists Midyear Clinical Meeting, Atlanta Georgia, December 1997.

96. Pizzi LT, Laskin MS, Gibson GA. Fishbone analysis of digoxin adverse drug events at a large teaching institution. Poster presentation at the American Society of Health-System Pharmacists Midyear Clinical Meeting, Atlanta Georgia, December 1997.

97. Pizzi LT, Kinky DE, Erush SA, Gibson GA. Development of a cost-consequence model to evaluate new drugs for formulary addition. Poster presentation at the American Society of Health-System Pharmacists Midyear Clinical Meeting, Atlanta Georgia, December 1997.

98. Pizzi LT, Gibson GA. Development of a skeletal muscle blocking agent formulary streamlining process. Platform presentation at the American Society of Health-System Pharmacists Midyear Clinical Meeting, Atlanta Georgia, December 1997.

99. Pizzi LT, Gibson GA, and Laskin M. Incidence and cost of ivig-induced thromboembolic events: a pharmacoepidemiologic and pharmacoeconomic analysis. Platform presentation at the Eastern States Residency Conference, Baltimore Maryland, May 1997.

100. Haplea SS, Farrar J, Gibson GA, Pizzi LT, Laskin M, and Asbury AK. Thromboembolic events associated with intravenous immuneglobulin. Poster presentation at the American Academy of Neurology (AAN) Annual Meeting, Boston Massachusetts, April 1997.

Publications, Submitted or in Development:

1. Schafer JJ, Prioli KM, Cannon-Dang E, Pizzi LT. Exploring Beliefs about Pneumococcal Vaccination in a Predominantly Older African American Population: The Pharmacists’ Pneumonia Prevention Program (PPPP). Research manuscript accepted by Ethnicity and Health, pending authors’ revision March 2018.

2. Jutkowitz E, Scerpella D, Pizzi LT, Marx K, Huang J, Samus Q, Piersol C, Gitlin LN. Dementia Family Caregiver’s Willingness to Pay for Tailored In-home Support Interventions. Research manuscript under review by PharmacoEconomics, March 2018.

3. Prioli KM, Herman JH, Katz-Karp J, Lyons NM, Chrebtow V, Pizzi LT. Economic Implications of Pathogen Reduced and Bacterially Tested Platelet Components: A US Hospital Budget Impact Model. Research manuscript submitted to Applied Health Economics and Health Policy, March 2018.

4. Smart M, Seligman NS, Gray L, Prioli KM, Berghella V, Pizzi LT. The Cost and Effectiveness of Serial Cervical Length Screening to Prevent Preterm Birth Among High-Risk US Women: A Decision Analysis. Research manuscript in development for the American Journal of Obstetrics and Gynecology.

5. Samus QM, Smith-Black B, Reuland M, Leoutsakos J, Pizzi L, Frick K, Roth DL, Gitlin LN,

Laura T. Pizzi Page 21

Johnston D. MIND at Home-Streamlined: Study protocol for a randomized trial of home-based care coordination for persons with dementia and their caregivers. Submitted to Contemporary Clinical Trials and under review.

6. Pizzi LT, Murchison AP, Hark LA, Leiby BE, Dai Y, Fulginiti J, and Haller JA. Relationship between reported common chronic medications and adherence to diabetic retinopathy care: implications for pharmacists. Manuscript developed and under authors’ review.

7. Pizzi LT, Jutkowitz E, Lyons N, Fortinsky R, Prioli KM, Samus Q, Frick K, Gitlin LN. Developing Consistency in Cost Analyses of Dementia Behavioral Interventions: A Review of Seven Protocols. Review article in development for Journal of the American Geriatrics Society.

8. Pizzi LT, Amos T, Murchison A, Bilyk JR. Cost effectiveness of repairing canalicular lacerations in the operating room vs. emergency department: Decision analytic model based on a retrospective analysis cases presenting to a large eye care hospital. Manuscript developed and under authors’ review.

9. Murchison AP, Hark L, Storey PP, Pizzi LT, Dai Y, Leiby BE, Haller JA. Eye care utilization by patients with diabetes: A large-scale retrospective analysis. Manuscript developed and under authors’ review.

10. Pizzi LT, Jutkowitz E, Prioli KM, Gitlin LN, Fortinsky RH. Intervention Delivery Costs and Caregivers’ Willingness to Pay for COPE-CT: Interim Findings. Submitted to the Gerontological Society of America Annual Meeting, 2018.

11. Jutkowitz E, Pizzi LT, Scerpella D, Marx, Samus Q, Piersol C, Gitlin LN. A Longitudinal Evaluation of Dementia Informal Caregiver’s Willingness to Pay for an In-home Nonpharmacologic Intervention to Reduce Behavioral Symptoms. Submitted to the Gerontological Society of America Annual Meeting, 2018.

12. Prioli KM, Herman JH, Katz-Karp J, Lyons NM, Chrebtow V, Pizzi LT. Cost and Shelf Life Implications of Pathogen-Reduced Platelets: A Hospital Budget Impact Model. Research abstract submitted for the ISPOR 23rd Annual International Meeting.

13. Mehta R, Prioli KM, Hark L, Katz LJ, Pizzi LT. Baseline Health Utility Scores in Subjects with Suspected Ocular Disease: An Analysis of the Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study. Research abstract submitted for the ISPOR 23rd Annual International Meeting.

14. Prioli KM, Schafer JJ, Formal R, Fields-Harris L, Jackson F, Pizzi LT. Baseline Knowledge about Vaccines and Vaccine-Preventable Diseases Among Older Adults: Analysis of the Vaccine Education Through Pharmacists and Senior Centers Study. Research abstract submitted for the ISPOR 23rd Annual International Meeting.

15. Smart M, Prioli KM, Seligman N, Pizzi LT. Cost-Effectiveness of Serial Cervical Length Screening to Prevent Preterm Birth Among High Risk US Women: A Decision Analysis. Research abstract submitted for the ISPOR 23rd Annual International Meeting.

16. Dharamdasani T, Akincigil A, DiCesare J, Johnson K, Pizzi LT. Association Between Insurance Type and Level of Care in Community-Living Patients with Alzheimers Disease and Related Dementias. Research abstract submitted for the ISPOR 23rd Annual International Meeting.

17. Willke R, Pizzi L, Perfetto E, Harris J, Khan Z, Ung B. gene and/or Brian Ung, Enabling ISPOR Member and Patient Advocacy Group Research Collaboration: A Volunteer Plan. Submitted as a Forum proposal for the ISPOR 23rd Annual International Meeting.

18. Murray J, Pizzi L, Wilke R. The ISPOR Health Economics and Outcomes Research Competencies Framework™: Guiding Professional Development for the Field. Submitted as a Forum proposal for the ISPOR 23rd Annual International Meeting.

Laura T. Pizzi Page 22

Seminars and Workshops: January 2018 Economic Modeling: A Primer Based on the Requirements of the Academy of Managed Care Pharmacy, Ernest Mario School of Pharmacy, Piscataway NJ.

October 2017 Health Outcomes, Policy, and Economics at Rutgers: Vision and

Strategy. Bowers Conference, Ernest Mario School of Pharmacy, Piscataway NJ. July 2017 Research Showcase: Health Outcomes, Policy, and Economics. Rutgers

Institute for Pharmaceutical Industry Fellowships Professional Development Day, Piscataway NJ.

2016 Community Report on the Pharmacists’ Pneumonia Prevention Project. Center in the Park, Philadelphia PA.

April 2015 Cost and Outcomes of the Pharmacists’ Pneumonia Prevention Project. Faculty Research Seminar. Jefferson College of Pharmacy, Philadelphia PA.

April 2015 Applied Health Economics in Action: Examples of Ongoing Cost and Cost Effectiveness Studies at Jefferson. Department of Family and Community Medicine Research Seminar, Sidney Kimmel Medical College, Philadelphia PA

February 2015 Preparing for Faculty Promotion: Suggestions towards Success. Faculty Development Lunch and Learn, Jefferson College of Pharmacy, Philadelphia PA.

June 2012-2015 Cost Analyses of Interventions in Older Adults, Summer Research Institute, School of Nursing, Johns Hopkins University, Baltimore MD

March 2014 Publishing Evidence for Today’s Health Decision Makers: Health Economics and Outcomes Research for Medical Writers and Publication Professionals. Drug Information Association Medical Communications Conference, Orlando FL.

March 2014 The Children’s Eye Care Adherence Program: Is it Cost-Effective for Wills

to Hire a Pediatric Social Worker? Presentation at the 66th Annual Wills Eye Hospital Annual Alumni Conference, Philadelphia PA.

December 2013 Burden of Eye Diseases: A Call to Action for Pharmacists. The Critical Role of the Pharmacist in Improving Outcomes for Patients with Common Eye Disorders. Continuing Education satellite symposium in partnership with Wills Eye Hospital held at the American Society for Health Systems Pharmacists, Orlando FL.

December 2013 Cost-effectiveness of a Major Glaucoma Detection Initiative in Philadelphia. Presentation at: CDC’s Glaucoma Detection Project: Targeting High Risk Populations in Pennsylvania and Alabama. U.S. Centers for Disease Control and Prevention, Atlanta GA.

October 2013 Economic Analyses for Diseases of Aging. Monthly Research Seminar, Jefferson School of Population Health, Philadelphia PA.

September 2013 Panel Moderator. The Critical Role of the Pharmacist in Improving

Laura T. Pizzi Page 23

Outcomes for Patients with Common Eye Disorders. Continuing Education program in partnership with Wills Eye Hospital held at the Union League, Philadelphia PA.

September 2013 Cost Effectiveness of Mindfulness-Based Art Therapy (MBAT) in Women with Breast Cancer. Presentation at: Applying Evidence from Economic Evaluations to Translate Cancer Survivorship Research into Care. National Cancer Institute, Rockville MD.

August 2013 Faculty as Researchers: Expectations, Opportunities, and Resources at Jefferson. New Faculty Orientation, Thomas Jefferson University, Philadelphia PA

June 2013 Update on the Vision Cost Special Interest Group. Wills Vision Research at Jefferson Annual Symposium, Wills Eye Hospital, Philadelphia PA

May 2013 Keynote Speaker, Annual Awards Luncheon, The Dolphins of Delaware Valley, Wayne PA

May 2013 Reactor Panelist, 22nd Annual Grandon Lecture, Jefferson School of Population Health, Philadelphia PA

April 2013 Getting Engaged in Scholarship. Discussion with Jefferson College of Pharmacy students (organized by JSP Student Body Governance and Student Society of Health System Pharmacy).

March 2013 Pharmacoeconomics as a Career Path. Presentation to Jefferson College of Pharmacy chapter of APhA-ASP.

May 2012 Economic Considerations in a Changing ESRD Anemia Environment. Invited continuing education lecture to the Mid-Atlantic College of Clinical Pharmacy, Philadelphia PA.

November 2011 Methods in Economic Analysis of Patient Support Programs in Aging.

Pre-Conference Workshop. Gerontological Society of America 64th

Annual Scientific Meeting, Boston MA.

June 2011 Cost Effectiveness of Vision Care. Invited Presentation at the Jefferson Vision Research Center at Wills Inaugural Retreat, Wills Eye Hospital, Philadelphia PA

June 2010 and 2011 Use of Surveys in Health Services Research. Invited lecture to the Health Services Research class, Jefferson School of Population Health, Philadelphia PA

November 2010 Methods in Economic Analysis of Patient Support Programs in Ageing. Workshop at the ISPOR European Congress, Prague, Czech Republic.

September 2010 Laying the Groundwork for Pharmacy Quality Measurement: Results from the Evaluation of the PQA Phase I Demonstration Project. AHRQ Annual Conference, Bethesda, MD

August 2010 Adjusting Costs and Outcomes in Health Economic Analysis. Invited lecture to the Economic Evaluation in Healthcare Class, Jefferson College of Graduate Studies, Philadelphia, PA

July 2010 and 2011 How to Write a Fundamentally Fundable Research Proposal. Invited lecture to the Medical and Scientific Writing class, Jefferson College of Graduate Studies, Philadelphia PA

Laura T. Pizzi Page 24

March 2010 Applied Health Economics: Update from the Field and Case Study of Dermal Ablative Lasers. Invited lecturer for the New York Eye and Ear Infirmary Grand Rounds, Division of Otolaryngology, New York, NY

February 2010 Comparative Effectiveness Research: An Interactive Case Study of Low Risk Prostate Cancer. Invited moderator for the American College of Medical Quality Annual Conference, Crystal City, VA

September 2009 The Pharmacist's Role in Quality: Is the Profession Ready? Invited panelist. Agency for Healthcare Research and Quality (AHRQ) Annual Conference, Bethesda, MD

March 2008 Economics of Anemia Treatment in End Stage Renal Disease. Invited presentation given at the Renal Physicians Association (RPA) Symposium, Austin, TX

December 2007 Pharmacoeconomics for Medical Communications Professionals: What You Need to Know. Moderator of one-day training program at OrthoMcNeil Janssen Scientific Affairs, LLC, Titusville, NJ.

April 2007 The Employer’s Role in Influencing Patient Compliance and Adherence.

Invited presentation to the Center for Business Intelligence (CBI) 6th

Annual Forum on Patient Compliance and Persistency, Philadelphia PA.

January 2007 Bariatric Surgery: Communicating the Value to Healthcare Payors and Purchasers. Invited presentation to the Tri-State Bariatric Surgical Association at Temple University, Philadelphia PA.

May 2006 Collecting and Using Productivity Data Alongside Clinical Trials. Workshop at the Podium presentation at the 11th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Philadelphia PA.

January 2006 Minimally Invasive: Minimally Reimbursed? Strategies for Employers Concerned with Surgical Value. Invited presentation to the NY Business Group on Health, New York NY.

November 2005 Economic Modeling Training Workshop. Invited presentation to international group of Johnson and Johnson employees, East Brunswick NJ

July 2005 Advanced Economic Modeling Training Program. Presentation to AstraZeneca U.S. employees, Philadelphia PA

November 2004 Quality of Life and Work Lost in Patients with Inflammatory Bowel Disease (IBD). Presentation to the Crohn’s and Colitis Foundation of America (CCFA) Patient Support Group, Philadelphia-area chapter, Philadelphia PA.

Committees: 2018 Co-Chair, Work Group to Establish Competencies for New

Professionals in Health Economics and Outcomes Research, International Society for Pharmacoeconomics and Outcomes Research

2017-present Member, Rutgers Population Health Working Group, Rutgers

Biomedical and Health Sciences, Newark NJ

Laura T. Pizzi Page 25

2015-2017 Member, EPIC Governance Academic Advisory Committee, Thomas Jefferson University Hospital

2015-2017 Member, Governance Committee, Jefferson College of Pharmacy

2014-2017 Member, Jefferson Committee on Research (JCOR), as well as Communication Subcommittee, Deans Transformational Science Award Subcommittee, and Interprofessional Research Subcommittee, Thomas Jefferson University

2008-2017 Member, Pharmacoeconomics and Clinical Effectiveness (PEACE) Committee, Thomas Jefferson University Hospital

2012-2014 Special Interest Group Leader, Vision Cost Research, Wills Center for Vision Research at Jefferson

2011-2014 Chair, Faculty Affairs Committee, Jefferson College of Pharmacy

2013 Faculty Representative from Jefferson College of Pharmacy to Thomas Jefferson University Lindback Award Selection Committee

2012 Interim Member, Faculty Senate, Thomas Jefferson University

2011-2102 Faculty Representative, Executive Council, Jefferson College of Pharmacy

2010 Member, Educational Mission and Program Planning Committee, Thomas Jefferson University

2009-2010 Chair, Committee on Research, Jefferson School of Population Health

2009 Member, Grade Appeals Board, Thomas Jefferson University

2007-2008 Member, Jefferson School of Population Health Planning Task Force

2007-2008 Member, Jefferson College of Pharmacy Curriculum Steering Committee

2004-2009 Member, Jefferson Masters in Public Health (MPH) Advisory Committee

2005 Member, Strategic Planning Committee, Jefferson College of Pharmacy

Congressional Testimony

December 2006 Testimony, U.S. House of Representatives Committee on Ways and Means, Hearing on Patient Safety and Quality Issues in End Stage Renal Disease Treatment, December 6, 2006. Available at: http://waysandmeans.house.gov/hearings.asp?formmode=view&id=5370

Editorial Board Memberships

2012-present Deputy Editor, American Health and Drug Benefits

2011-present Editorial Board, PharmacoEconomics

2012-2017 Editorial Board, Population Health Matters

Laura T. Pizzi Page 26

Other Relevant Activities:

2018 Founding Board Member, Employer Provider Interface Council (EPIC)

2017-present Co-Chair, Workgroup to Establish a Competency Inventory for New Professionals in Health Economics and Outcomes Research, International Society for Pharmacoeconomics and Outcomes Research

2017 Advisory Board Member, Diabetes Health Economics and Outcomes Research, Novo Nordisk.

2007-2017 Media Advisor, American Pharmacists Association

2006-2017 Faculty Advisor, Thomas Jefferson University Student Chapter of the International Society of Pharmacoeconomics and Outcomes Research (Jeff-ISPOR), Philadelphia PA (recognized as Student Organization of the Year in 2014 by the Jefferson Activities Office)

2015, 2016 Abstract reviewer for cost study submissions, Alzheimer’s Association International Conference, Washington DC, July 2015

2015 Invited chapter reviewer, 2nd U.S. Panel on Cost Effectiveness in Health and Medicine

2015 External reviewer, Comparative Effectiveness Research and Health Care Decision-Making. Editor: Carl Asche, PhD

2014-2015 Participant, Teaching for Quality (Te4Q) leadership program, American Association of Medical Colleges (AAMC)

2014 Reviewer, Health Affairs and the Clinical Journal of the American Society of Nephrology

2012 Participant, International Society for Pharmacoeconomics and Outcomes Research Vision 2020 Leadership Task Force

2011-2013 Member, Technical Expert Panel, AHRQ Pharmacy Survey on Patient Safety Culture (SOPS)

2011 Reviewer for Journal of Aging Research, Current Medical Research and Opinion, Journal of Aging Research, Clinical Journal of the American Society of Nephrology

2010 Member, Pharmacoeconomics National Faculty Council, Centocor Ortho Biotech Inc.

2010 Reviewer, Clinical Therapeutics, Clinical Journal of Pain, and Journal of Pharmaceutical Health Services Research

2010 Co-editor for Journal of Facial Plastic Surgery for special issue on economics and outcomes of plastic surgery

2009-present Member, Student Chapter Faculty Advisor Council, International Society for Pharmacoeconomics and Outcomes Research

2007- 2008 Member, Quality Council, Stonybrook University Medical Center, Islip NY

2005-2007 Moderator, Research Presentation Sessions, Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR)

2004 Participant, Partnerships for Health: Informing Policy and Practice in

Laura T. Pizzi Page 27

Pennsylvania. Harrisburg, PA. Meeting funded by the Agency for Healthcare Research and Quality and facilitated by Academy Health

2002 Reviewer, National Safety Council Annual Awards for Safety and Productivity

Licensure: Registered Pharmacist (Pennsylvania License # RP-042679-L); license is active

Awards and Honors:

2016 Pizzi L, Jutkowitz E, Marx K, Gitlin L. What are Family Caregivers Willing to Pay for an Intervention to Address Behavioral Symptoms? Selected for Ollie Randall Symposium (recognition given to “high-quality submissions that examine cutting- edge issues with broad implications for policy or practice”). Gerontological Society of America Annual Meeting, New Orleans LA, November 2016.

2015 Poster finalist ribbon, ISPOR Annual Meeting

2014 Excellence in Scholarly Research Award, Jefferson College of Pharmacy

2014 American Association of Colleges of Pharmacy (AACP) Teacher of the Year Award, Jefferson College of Pharmacy

2013 Poster finalist ribbon, ISPOR Annual Meeting

2013 Top Poster Award, American Association of Blood Banks (AABB) Annual Meeting

2013 Dean’s Faculty Achievement Award, Jefferson College of Pharmacy

2012 Best poster award, Challenges in Critical Care Conference, Pennsylvania Society for Critical Care Medicine (PASCCM)

2010 Poster finalist ribbon, ISPOR European Congress

2005 Best Podium Presentation, ISPOR European Congress

2003 Medstat Investigator Award

Memberships in Professional Societies:

International Society for Pharmacoeconomics and Outcomes Research (ISPOR)

American Pharmacists Association (APhA)

Pennsylvania Pharmacists Association (PPA)

American Society of Health-System Pharmacists (ASHP)

Current Research Support (March 2018):

NIH, CDC, CERUS Inc., Merck and Co. (Investigator Initiated Studies Program)